NCT02779855 2026-03-10Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Completed50 enrolled 12 charts